Exicure XCUR
NASDAQ XCUR
$1.16 +0.04 (+3.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Exicure (XCUR) Non Operating Investment Income (2025 - 2026)

Updated

Exicure's Non Operating Investment Income was $9,000 in Q2 2026, compared with -$60,000 a year earlier.

Analysis

Exicure (XCUR) Non Operating Investment Income (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Exicure's Non Operating Investment Income was -$32,000 through Jun 30, 2026; for FY2025, it came in at -$90,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Exicure 7.39 Mn 7.39 Mn - 9,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,000.00
Mar 31, 2026 -37,000.00
Sep 30, 2025 -4,000.00
Jun 30, 2025 -60,000.00
Mar 31, 2025 -26,000.00
API Access

Exicure Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=XCUR&period=max&api_key=YOUR_API_KEY